A Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Trial to Evaluate the Equivalence in Efficacy and Safety of HD203 and Enbrel in Combination With Methotrexate in Patients With Rheumatoid Arthritis.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2016
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms HERA
- Sponsors Hanwha Chemical
- 23 Feb 2016 Results published in the Annals of the Rheumatic Diseases
- 14 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Jun 2011 Status changed from not yet recruiting to recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History